The article discusses the orphan drug rule for 340B drug discount program published by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) on July 23, 2013. The regulation increases the number of entities to which pharmaceutical ...
HRSA Releases Proposed Rule Governing the Administrative Dispute Resolution Process for 340B-Related ClaimsMichael H. Hinckle
of 340B agency.]]>Reports on the United States Health Resources and Services Administration's (HRSA) overhaul of the Office of Pharmacy Affairs (OSA). Review of drug purchases; Failure of HRSA to have protocols for ensuring that entities enrolled in OSA receive appropriate discounts from drug...
Richard P. Church
HRSA Finalizes 340B Program Orphan Drug Exclusion RulesEmily J. CookDavid S. Ivill
Christopher H. Schott
Health Resources and Services Administration published the early results of its covered entity audits for its 2013 fiscal year and mentions topics like a hospital mentioned in the report for dispensing 340B program medications not backed by the medical record....
HRSA Clarifies 340b Orphan Drug Exception but 340b Audit Enforcement Remains MurkySternfield, Ellyn
HRSA Publishes 340B Drug Pricing Program Omnibus Guidance Notice: Significant Policy Ramifications Should Trigger Public CommentJoseph W. Metro
340B Program: HRSA Posts Orphan Drug Exclusion Policy, PhRMA RespondsNatalie D. MorrisChristopher H. SchottAlice Valder Curran